News tagged with pharmacology
Study: Rapid bone loss as possible side effect of anti-obesity drug now in clinical trials
An endocrine hormone used in clinical trials as an anti-obesity and anti-diabetes drug causes significant and rapid bone loss in mice, raising concerns about its safe use, UT Southwestern Medical Center researchers ...
Feb 07, 2012 |
3 / 5 (1) |
1
|
Why the brain is more reluctant to function as we age
New findings, led by neuroscientists at the University of Bristol and published this week in the journal Neurobiology of Aging, reveal a novel mechanism through which the brain may become more reluctant to function as we ...
Medicine & Health / Neuroscience
Feb 01, 2012 |
3.9 / 5 (7) |
0
|
Protein in the brain could be a key target in controlling Alzheimer's
A protein recently discovered in the brain could play a key role in regulating the creation of amyloid beta, the major component of plaques implicated in the development of Alzheimer's disease, according to researchers at ...
Medicine & Health / Neuroscience
Jan 25, 2012 |
5 / 5 (2) |
0
|
Starting smoking cessation medication earlier may make it easier to quit
Smokers planning to kick the habit may have more success if they begin using a cessation medication several weeks before they actually try to quit. Those are the results of a clinical trial conducted by researchers at the ...
Jan 05, 2012 |
5 / 5 (1) |
1
US Patent Office affirms 'Zamore Design Rule' patents
The United States Patent and Trademark Office has reaffirmed the validity of four important patents in the field of RNA therapeutics.
Dec 12, 2011 |
5 / 5 (1) |
0
Pharmacists crucial in plan for terrorist chemical weapons
Terrorist attacks with chemical weapons are a real possibility, according to a study that appears in the online open access journal, Journal of Pharmacy Practice, published by SAGE. Thanks to their extensive knowledge of tox ...
Dec 10, 2011 |
not rated yet |
1
When prophecy fails: How to better predict success in HIV prevention clinical trials
New research from the University of North Carolina at Chapel Hill schools of medicine and pharmacy may help explain the failure of some recent clinical trials of prevention of HIV infection, compared to the ...
Medicine & Health / HIV & AIDS
Dec 07, 2011 |
not rated yet |
0
|
Researchers study toenails as marker for arsenic exposure
(PhysOrg.com) -- UA scientists have teamed up to study the relationship between arsenic in human toenails and arsenic concentration in drinking water. Exposure to arsenic is associated with several chronic diseases ranging ...
Dec 07, 2011 |
not rated yet |
0
New protocols improve detection of microRNAs for diagnosis
MicroRNAs (miRNAs) that regulate processes including fertilization, development, and aging show promise as biomarkers of disease. They can be collected from routinely collected fluids such as blood, saliva, and urine. However, ...
Dec 07, 2011 |
5 / 5 (1) |
0
Tumor-targeting compound points the way to new personalized cancer treatments
One major obstacle in the fight against cancer is that anticancer drugs often affect normal cells in addition to tumor cells, resulting in significant side effects. Yet research into development of less harmful treatments ...
Dec 01, 2011 |
not rated yet |
0
|
Clinical trial for muscular dystrophy demonstrates safety of customized gene therapy
Researchers at the University of North Carolina at Chapel Hill have shown that it is safe to cut and paste together different viruses in an effort to create the ultimate vehicle for gene therapy. In a phase I clinical trial, ...
Nov 30, 2011 |
not rated yet |
0
|
Paracetamol: Repeated ingestion of slightly too much can be fatal -- recognize and treat quickly
Repeatedly taking slightly too much paracetamol over time can cause a dangerous overdose that is difficult to spot, but puts the person at danger of dying. Patients may not come to hospital reporting the overdose, but because ...
Medicine & Health / Medications
Nov 23, 2011 |
5 / 5 (3) |
6
New class of drugs for the reversible inhibition of proteasomes
As the "recycling plant" of the cell, the proteasome regulates vitally important functions. When it is inhibited, the cell chokes on its own waste. Cancer cells, in particular, are very sensitive because they ...
Nov 22, 2011 |
not rated yet |
0
New hi-tech survey accelerates collection of vaccination data
New technology now makes it possible to collect 'near real-time' data about whether people are having any side effects from vaccination. By studying people who received the 2009-10 swine flu vaccination in Scotland, researchers ...
Medicine & Health / Medications
Nov 15, 2011 |
not rated yet |
0
Nano-tech makes medicine greener
Over the last 5 years the Bionano Group at the Nano-Science Center and the Department of Neuroscience and Pharmacology at the University of Copenhagen has been working hard to characterise and test how molecules react, combine ...
Nanotechnology / Bio & Medicine
Nov 03, 2011 |
5 / 5 (3) |
0
|
Pharmacology
Pharmacology (from Greek φάρμακον, pharmakon, "poison in classic Greek; drug in modern Greek"; and -λογία, "Study of" -logia) is the branch of medicine and biology concerned with the study of drug action. More specifically, it is the study of the interactions that occur between a living organism and chemicals that affect normal or abnormal biochemical function. If substances have medicinal properties, they are considered pharmaceuticals. The field encompasses drug composition and properties, interactions, toxicology, therapy, and medical applications and antipathogenic capabilities. The two main areas of pharmacology are pharmacodynamics and pharmacokinetics. The former studies the effects of the drugs on biological systems, and the latter the effects of biological systems on the drugs. In broad terms, pharmacodynamics discusses the interactions of chemicals with biological receptors, and pharmacokinetics discusses the absorption, distribution, metabolism, and excretion of chemicals from the biological systems. Pharmacology is not synonymous with pharmacy and the two terms are frequently confused. Pharmacology deals with how drugs interact within biological systems to affect function. It is the study of drugs, of the reactions of the body and drug on each other, the sources of drugs, their nature, and their properties. In contrast, pharmacy is a biomedical science concerned with preparation, dispensing, dosage, and the safe and effective use of medicines.[citation needed]
Dioscorides' De Materia Medica is often said to be the oldest and most valuable work in the history of pharmacology. The origins of clinical pharmacology date back to the Middle Ages in Avicenna's The Canon of Medicine, Peter of Spain's Commentary on Isaac, and John of St Amand's Commentary on the Antedotary of Nicholas. Clinical pharmacology owes much of its foundation to the work of William Withering. Pharmacology as a scientific discipline did not further advance until the mid-19th century amid the great biomedical resurgence of that period. Before the second half of the nineteenth century, the remarkable potency and specificity of the actions of drugs such as morphine, quinine and digitalis were explained vaguely and with reference to extraordinary chemical powers and affinities to certain organs or tissues. The first pharmacology department was set up by Rudolf Buchheim in 1847, in recognition of the need to understand how therapeutic drugs and poisons produced their effects.
Early pharmacologists focused on natural substances, mainly plant extracts. Pharmacology developed in the 19th century as a biomedical science that applied the principles of scientific experimentation to therapeutic contexts.
For more information about Pharmacology, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.